Phosphodiesterase‐5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure

Phosphodiesterase‐5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure

Abstract Aims Phosphodiesterase‐5 inhibitors (PDE5I) are frequently implemented after left ventricular assist device (LVAD) implantation to improve haemodynamics in patients with early postoperative right ventricular (RV) failure. It is unknown if long‐term PED5I therapy beyond the early post‐operat...

Full description

Bibliographic Details
Main Authors: Maria Papathanasiou, Aiste‐Monika Jakstaite, Raluca Mincu, Simon Wernhart, Arjang Ruhparwar, Tienush Rassaf, Peter Luedike
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:ESC Heart Failure
Subjects:
Mechanical circulatory support
Right ventricle
Pulmonary hypertension
Phosphodiesterase‐5 inhibitors
Online Access:https://doi.org/10.1002/ehf2.14366

Internet

https://doi.org/10.1002/ehf2.14366

Similar Items